Ark Life Science Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 19 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
About Ark Life Science
Ark Life Science Private Limited (ALSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 04 October 2005 and has a history of 19 years and three months. Its registered office is in Delhi, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Krishna Aggarwal, Arun Aggarwal, and Seema Aggarwal serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24232DL2005PTC141440
- Company No.
141440
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Oct 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Ark Life Science Private Limited offer?
Ark Life Science Private Limited offers a wide range of products and services, including Decorative Light, Lamp & Lamp Shades, Decorative Light, Medical Surgery & Treatment Centres, Medical Treatment Services, Indoor Lights & Lighting Accessories, Reading Light, Wall Light, Garden & Landscaping Products, Garden Lighting.
Who are the key members and board of directors at Ark Life Science?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Seema Aggarwal  | Director | 15-Jan-2009 | Current |
| Krishna Aggarwal | Additional Director | 04-Oct-2024 | Current |
| Arun Aggarwal | Director | 04-Oct-2005 | Current |
Financial Performance of Ark Life Science.
Ark Life Science Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ark Life Science?
In 2016, Ark Life Science had a promoter holding of 60.00% and a public holding of 40.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ark Life Science?
Unlock and access historical data on people associated with Ark Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ark Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ark Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
